K. Rajender Reddy

67.0k total citations · 13 hit papers
586 papers, 37.2k citations indexed

About

K. Rajender Reddy is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, K. Rajender Reddy has authored 586 papers receiving a total of 37.2k indexed citations (citations by other indexed papers that have themselves been cited), including 462 papers in Hepatology, 376 papers in Epidemiology and 112 papers in Surgery. Recurrent topics in K. Rajender Reddy's work include Liver Disease Diagnosis and Treatment (320 papers), Hepatitis C virus research (253 papers) and Liver Disease and Transplantation (208 papers). K. Rajender Reddy is often cited by papers focused on Liver Disease Diagnosis and Treatment (320 papers), Hepatitis C virus research (253 papers) and Liver Disease and Transplantation (208 papers). K. Rajender Reddy collaborates with scholars based in United States, Canada and Germany. K. Rajender Reddy's co-authors include Chalermrat Bunchorntavakul, Eugene R. Schiff, Mitchell L. Shiffman, Michael Fried, Lennox J. Jeffers, Coleman I. Smith, Joseph H. Hoffman, M. Diago, Dieter Häussinger and Daniel Dhumeaux and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

K. Rajender Reddy

557 papers receiving 36.2k citations

Hit Papers

Peginterferon Alfa-2a plu... 2000 2026 2008 2017 2002 2011 2002 2008 2000 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
    2002 5.1k citations Michael Fried, Mitchell L. Shiffman et al. profile →
  2. Boceprevir for Untreated Chronic HCV Genotype 1 Infection
    2011 1.9k citations Mark Sulkowski, Ira M. Jacobson et al. profile →
  3. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
    2002 1.7k citations Lennox J. Jeffers, K. Rajender Reddy et al. The American Journal of Gastroenterology profile →
  4. Diagnosis and Treatment of Hepatocellular Carcinoma
    2008 914 citations Jorge A. Marrero, K. Rajender Reddy et al. Gastroenterology profile →
  5. Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
    2000 682 citations Mitchell L. Shiffman, Geoffrey Dusheiko et al. profile →
  6. American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
    2014 651 citations K. Rajender Reddy, Joseph K. Lim et al. Gastroenterology profile →
  7. α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
    2009 557 citations Jorge A. Marrero, Ziding Feng et al. Gastroenterology profile →
  8. Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures
    2014 406 citations Jasmohan S. Bajaj, Jacqueline G. O’Leary et al. Hepatology profile →
  9. Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
    2015 386 citations K. Rajender Reddy et al. profile →
  10. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
    2020 338 citations K. Rajender Reddy et al. Hepatology profile →
  11. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network
    2014 292 citations K. Rajender Reddy et al. Hepatology profile →
  12. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
    2021 246 citations Florence Wong, K. Rajender Reddy et al. profile →
  13. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
    2021 218 citations K. Rajender Reddy et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Rajender Reddy United States 88 28.3k 24.9k 5.3k 3.9k 3.3k 586 37.2k
Jay H. Hoofnagle United States 109 30.1k 1.1× 30.6k 1.2× 4.2k 0.8× 3.8k 1.0× 3.8k 1.2× 393 43.8k
Stefan Zeuzem Germany 101 34.2k 1.2× 32.8k 1.3× 4.1k 0.8× 5.0k 1.3× 1.1k 0.3× 1.0k 47.0k
Michael Fried United States 80 18.4k 0.7× 17.0k 0.7× 3.8k 0.7× 3.1k 0.8× 1.0k 0.3× 473 28.7k
Zachary Goodman United States 88 31.0k 1.1× 33.3k 1.3× 4.5k 0.8× 3.4k 0.9× 642 0.2× 299 42.1k
Thierry Poynard France 93 33.9k 1.2× 36.1k 1.5× 4.3k 0.8× 2.8k 0.7× 817 0.2× 427 43.7k
William M. Lee United States 84 19.4k 0.7× 16.2k 0.7× 3.5k 0.7× 1.5k 0.4× 11.5k 3.5× 385 32.7k
Anna S. Lok United States 105 39.5k 1.4× 40.9k 1.6× 3.9k 0.7× 3.7k 1.0× 720 0.2× 557 48.3k
David E. Kleiner United States 100 17.6k 0.6× 32.1k 1.3× 7.3k 1.4× 2.2k 0.6× 2.8k 0.8× 515 50.7k
Mitchell L. Shiffman United States 75 27.9k 1.0× 27.7k 1.1× 3.1k 0.6× 2.8k 0.7× 655 0.2× 275 34.4k
Adrian M. Di Bisceglie United States 89 24.7k 0.9× 24.4k 1.0× 2.5k 0.5× 2.2k 0.6× 690 0.2× 385 34.5k

Countries citing papers authored by K. Rajender Reddy

Since Specialization
Citations

This map shows the geographic impact of K. Rajender Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Rajender Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Rajender Reddy more than expected).

Fields of papers citing papers by K. Rajender Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Rajender Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Rajender Reddy. The network helps show where K. Rajender Reddy may publish in the future.

Co-authorship network of co-authors of K. Rajender Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of K. Rajender Reddy. A scholar is included among the top collaborators of K. Rajender Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Rajender Reddy. K. Rajender Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roy, A. D., Karan Kumar, Madhumita Premkumar, et al.. (2024). Current status of etiology and outcomes of acute liver failure in India—A multicentre study from tertiary centres. Indian Journal of Gastroenterology. 44(1). 47–56. 3 indexed citations
3.
Bajaj, Jasmohan S., K. Rajender Reddy, Jacqueline G. O’Leary, et al.. (2020). Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Gastroenterology. 159(5). 1715–1730.e12. 81 indexed citations
4.
Lok, Anna S., Mark Sulkowski, Jens Kort, et al.. (2019). Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy. Gastroenterology. 157(6). 1506–1517.e1. 34 indexed citations
5.
Potluri, Vishnu S., David S. Goldberg, Sumit Mohan, et al.. (2019). National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys. Journal of the American Society of Nephrology. 30(10). 1939–1951. 54 indexed citations
6.
Dai, Jianliang, Neehar D. Parikh, Myron Schwartz, et al.. (2018). Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute’s Early Detection Research Network. Contemporary Clinical Trials. 76. 49–54. 18 indexed citations
7.
8.
Yang, Ju Dong, Jianliang Dai, Amit G. Singal, et al.. (2017). Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1085–1092. 45 indexed citations
9.
Foster, Graham R., Carmine Coppola, Moutaz Derbala, et al.. (2016). Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort. PLoS ONE. 11(3). e0151703–e0151703. 15 indexed citations
10.
Bunchorntavakul, Chalermrat & K. Rajender Reddy. (2015). Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection. Alimentary Pharmacology & Therapeutics. 42(3). 258–272. 40 indexed citations
11.
Giannini, Edoardo G., Nezam H. Afdhal, Samuel H. Sigal, et al.. (2015). Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy. Journal of Gastroenterology and Hepatology. 30(8). 1301–1308. 4 indexed citations
12.
Ampuero, Javier, Manuel Romero‐Gómez, & K. Rajender Reddy. (2014). Review article: HCV genotype 3 – the new treatment challenge. Alimentary Pharmacology & Therapeutics. 39(7). 686–698. 81 indexed citations
13.
Bahirwani, Ranjeeta, Marwan Ghabril, Kimberly A. Forde, et al.. (2013). Factors That Predict Short-term Intensive Care Unit Mortality in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 11(9). 1194–1200.e2. 21 indexed citations
14.
Shetty, Kirti, et al.. (2008). Prevalence and Significance of Occult Hepatitis B in a Liver Transplant Population With Chronic Hepatitis C. Liver Transplantation. 14(4). 534–540. 48 indexed citations
15.
Gish, Robert G., Nezam H. Afdhal, Douglas T. Dieterich, & K. Rajender Reddy. (2005). Management of hepatitis C virus in special populations: Patient and treatment considerations. Clinical Gastroenterology and Hepatology. 3(4). 311–318. 28 indexed citations
16.
Abt, Peter L., Kevin C. Mange, Kim M. Olthoff, et al.. (2004). Allograft Survival Following Adult-to-Adult Living Donor Liver Transplantation. American Journal of Transplantation. 4(8). 1302–1307. 79 indexed citations
17.
Lewis, James D., K. Rajender Reddy, Scarlett L. Bellamy, et al.. (2004). Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology. 40(4). 892–899. 27 indexed citations
18.
Jeffers, Lennox J., William M. Cassidy, Charles D. Howell, Sylvia Hu, & K. Rajender Reddy. (2004). Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology. 39(6). 1702–1708. 203 indexed citations
19.
Reddy, K. Rajender, et al.. (2003). Hepatotoxicity of hypolipidemic drugs. Clinics in Liver Disease. 7(2). 415–433. 65 indexed citations
20.
Méndez, Pedro, Kia Saeian, K. Rajender Reddy, et al.. (2001). Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations. The American Journal of Gastroenterology. 96(8). 2489–2493. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay H. Hoofnagle Breakdown of academic impact, for papers by Stefan Zeuzem Breakdown of academic impact, for papers by Michael Fried Breakdown of academic impact, for papers by Zachary Goodman Breakdown of academic impact, for papers by Thierry Poynard Breakdown of academic impact, for papers by William M. Lee Breakdown of academic impact, for papers by Anna S. Lok Breakdown of academic impact, for papers by David E. Kleiner Breakdown of academic impact, for papers by Mitchell L. Shiffman Breakdown of academic impact, for papers by Adrian M. Di Bisceglie
Rankless by CCL
2026